{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer", "berberine", "bioavailability", "mechanism", "safety"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35889396", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "28"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "15"}], "Language": ["eng"], "ELocationID": ["4523", "10.3390/molecules27144523"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "14", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "15"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review.", "Abstract": {"AbstractText": ["Cancer has been a serious public health problem. Berberine is a famous natural compound from medicinal herbs and shows many bioactivities, such as antioxidant, anti-inflammatory, antidiabetic, anti-obesity, and antimicrobial activities. In addition, berberine shows anticancer effects on a variety of cancers, such as breast, lung, gastric, liver, colorectal, ovarian, cervical, and prostate cancers. The underlying mechanisms of action include inhibiting cancer cell proliferation, suppressing metastasis, inducing apoptosis, activating autophagy, regulating gut microbiota, and improving the effects of anticancer drugs. This paper summarizes effectiveness and mechanisms of berberine on different cancers and highlights the mechanisms of action. In addition, the nanotechnologies to improve bioavailability of berberine are included. Moreover, the side effects of berberine are also discussed. This paper is helpful for the prevention and treatment of cancers using berberine."]}, "AuthorList": [{"Identifier": ["0000-0002-2978-0026"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China."}], "LastName": "Xiong", "ForeName": "Ruo-Gu", "Initials": "RG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China."}], "LastName": "Huang", "ForeName": "Si-Yu", "Initials": "SY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China."}], "LastName": "Wu", "ForeName": "Si-Xia", "Initials": "SX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China."}], "LastName": "Zhou", "ForeName": "Dan-Dan", "Initials": "DD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China."}], "LastName": "Yang", "ForeName": "Zhi-Jun", "Initials": "ZJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China."}], "LastName": "Saimaiti", "ForeName": "Adila", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China."}], "LastName": "Zhao", "ForeName": "Cai-Ning", "Initials": "CN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China."}], "LastName": "Shang", "ForeName": "Ao", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China."}], "LastName": "Zhang", "ForeName": "Yun-Jian", "Initials": "YJ"}, {"Identifier": ["0000-0002-4162-1511"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Plants and Human Health, Institute of Urban Agriculture, Chinese Academy of Agricultural Sciences, National Agricultural Science & Technology Center, Chengdu 610213, China."}], "LastName": "Gan", "ForeName": "Ren-You", "Initials": "RY"}, {"Identifier": ["0000-0003-2332-8554"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China."}], "LastName": "Li", "ForeName": "Hua-Bin", "Initials": "HB"}], "GrantList": [{"GrantID": "NASC2021KR01", "Agency": "Local Financial Funds of National Agricultural Science and Technology Center, Chengdu", "Country": ""}, {"GrantID": "2014B020205002", "Agency": "the Key Project of Guangdong Provincial Science and Technology Program", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Berberine"}, {"QualifierName": [], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Obesity"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Farha A.K., Gan R.Y., Li H.B., Wu D.T., Atanasov A.G., Gul K., Zhang J.R., Yang Q.Q., Corke H. The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives. Crit. Rev. Food Sci. Nutr. 2022;62:832\u2013859. doi: 10.1080/10408398.2020.1829541.", "ArticleIdList": ["10.1080/10408398.2020.1829541", "33054344"]}, {"Citation": "Gan R.Y., Li H.B., Sui Z.Q., Corke H. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Crit. Rev. Food Sci. Nutr. 2018;58:924\u2013941. doi: 10.1080/10408398.2016.1231168.", "ArticleIdList": ["10.1080/10408398.2016.1231168", "27645804"]}, {"Citation": "Li Y., Li S., Zhou Y., Meng X., Zhang J.J., Xu D.P., Li H.B. Melatonin for the prevention and treatment of cancer. Oncotarget. 2017;8:39896\u201339921. doi: 10.18632/oncotarget.16379.", "ArticleIdList": ["10.18632/oncotarget.16379", "PMC5503661", "28415828"]}, {"Citation": "Saimaiti A., Zhou D.D., Li J., Xiong R.G., Gan R.Y., Huang S.Y., Shang A., Zhao C.N., Li H.Y., Li H.B. Dietary sources, health benefits, and risks of caffeine. Crit. Rev. Food Sci. Nutr. p. 2022. in press .", "ArticleIdList": ["10.1080/10408398.2022.2074362", "35574653"]}, {"Citation": "Xu X.Y., Zhao C.N., Cao S.Y., Tang G.Y., Gan R.Y., Li H.B. Effects and mechanisms of tea for the prevention and management of cancers: An updated review. Crit. Rev. Food Sci. Nutr. 2020;60:1693\u20131705. doi: 10.1080/10408398.2019.1588223.", "ArticleIdList": ["10.1080/10408398.2019.1588223", "30869995"]}, {"Citation": "Zhao C.N., Li Y., Meng X., Li S., Liu Q., Tang G.Y., Gan R.Y., Li H.B. Insight into the roles of vitamins C and D against cancer: Myth or truth? Cancer Lett. 2018;431:161\u2013170. doi: 10.1016/j.canlet.2018.05.039.", "ArticleIdList": ["10.1016/j.canlet.2018.05.039", "29857128"]}, {"Citation": "Zheng J., Zhou Y., Li Y., Xu D.P., Li S., Li H.B. Spices for prevention and treatment of cancers. Nutrients. 2016;8:495. doi: 10.3390/nu8080495.", "ArticleIdList": ["10.3390/nu8080495", "PMC4997408", "27529277"]}, {"Citation": "Zhou Y., Zheng J., Li Y., Xu D.P., Li S., Chen Y.M., Li H.B. Natural polyphenols for prevention and treatment of cancer. Nutrients. 2016;8:515. doi: 10.3390/nu8080515.", "ArticleIdList": ["10.3390/nu8080515", "PMC4997428", "27556486"]}, {"Citation": "Wang K., Feng X.C., Chai L.W., Cao S.J., Qiu F. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab. Rev. 2017;49:139\u2013157. doi: 10.1080/03602532.2017.1306544.", "ArticleIdList": ["10.1080/03602532.2017.1306544", "28290706"]}, {"Citation": "Imenshahidi M., Hosseinzadeh H. Berberine and barberry (Berberis vulgaris): A clinical review. Phytother. Res. 2019;33:504\u2013523. doi: 10.1002/ptr.6252.", "ArticleIdList": ["10.1002/ptr.6252", "30637820"]}, {"Citation": "Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 2004;10:1344\u20131351. doi: 10.1038/nm1135.", "ArticleIdList": ["10.1038/nm1135", "15531889"]}, {"Citation": "Kumar A., Ekavali, Chopra K., Mukherjee M., Pottabathini R., Dhull D.K. Current knowledge and pharmacological profile of berberine: An update. Eur. J. Pharmacol. 2015;761:288\u2013297. doi: 10.1016/j.ejphar.2015.05.068.", "ArticleIdList": ["10.1016/j.ejphar.2015.05.068", "26092760"]}, {"Citation": "Neag M.A., Mocan A., Echeverria J., Pop R.M., Bocsan C.I., Crisan G., Buzoianu A.D. Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front. Pharmacol. 2018;9:557. doi: 10.3389/fphar.2018.00557.", "ArticleIdList": ["10.3389/fphar.2018.00557", "PMC6111450", "30186157"]}, {"Citation": "Chen Z., Vallega K.A., Chen H.Y., Zhou J., Ramalingam S.S., Sun S.Y. The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition. Pharmacol. Res. 2022;175:105998. doi: 10.1016/j.phrs.2021.105998.", "ArticleIdList": ["10.1016/j.phrs.2021.105998", "PMC8755628", "34826601"]}, {"Citation": "Gan R.Y. Bioactivities of berberine: An update. Int. J. Mod. Biol. Med. 2012;1:48\u201381."}, {"Citation": "Ortiz L.M.G., Lombardi P., Tillhon M., Scovassi A.I. Berberine, an epiphany against cancer. Molecules. 2014;19:12349\u201312367. doi: 10.3390/molecules190812349.", "ArticleIdList": ["10.3390/molecules190812349", "PMC6271598", "25153862"]}, {"Citation": "Wang N., Tan H.Y., Li L., Yuen M.F., Feng Y.B. Berberine and Coptidis rhizoma as potential anticancer agents: Recent updates and future perspectives. J. Ethnopharmacol. 2015;176:35\u201348. doi: 10.1016/j.jep.2015.10.028.", "ArticleIdList": ["10.1016/j.jep.2015.10.028", "26494507"]}, {"Citation": "Xia Y.Y., Chen S.Z., Cui J.F., Wang Y., Liu X.C., Shen Y.L., Gong L., Jiang X.W., Wang W.F., Zhu Y.F., et al. Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p. Biochem. Pharmacol. 2021;188:114575. doi: 10.1016/j.bcp.2021.114575.", "ArticleIdList": ["10.1016/j.bcp.2021.114575", "33887260"]}, {"Citation": "Khan S., Hussain A., Attar F., Bloukh S.H., Edis Z., Sharifi M., Balali E., Nemati F., Derakhshankhah H., Zeinabad H.A., et al. A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents. Biomed. Pharmacother. 2022;146:112531. doi: 10.1016/j.biopha.2021.112531.", "ArticleIdList": ["10.1016/j.biopha.2021.112531", "34906771"]}, {"Citation": "Zhang C., Sheng J., Li G., Zhao L., Wang Y., Yang W., Yao X., Sun L., Zhang Z., Cui R. Effects of berberine and its derivatives on cancer: A systems pharmacology review. Front. Pharmacol. 2019;10:1461. doi: 10.3389/fphar.2019.01461.", "ArticleIdList": ["10.3389/fphar.2019.01461", "PMC6974675", "32009943"]}, {"Citation": "Rauf A., Abu-Izneid T., Khalil A.A., Imran M., Shah Z.A., Emran T.B., Mitra S., Khan Z., Alhumaydhi F.A., Aljohani A.S.M., et al. Berberine as a potential anticancer agent: A comprehensive review. Molecules. 2021;26:7368. doi: 10.3390/molecules26237368.", "ArticleIdList": ["10.3390/molecules26237368", "PMC8658774", "34885950"]}, {"Citation": "Wang Y., Liu Y., Du X., Ma H., Yao J. The anti-cancer mechanisms of berberine: A review. Cancer Manag. Res. 2020;12:695\u2013702. doi: 10.2147/CMAR.S242329.", "ArticleIdList": ["10.2147/CMAR.S242329", "PMC6996556", "32099466"]}, {"Citation": "Li Y., Li S., Meng X., Gan R.Y., Zhang J.J., Li H.B. Dietary natural products for prevention and treatment of breast cancer. Nutrients. 2017;9:728. doi: 10.3390/nu9070728.", "ArticleIdList": ["10.3390/nu9070728", "PMC5537842", "28698459"]}, {"Citation": "Sun Y., Wang W.T., Tong Y.W. Berberine inhibits proliferative ability of breast cancer cells by reducing metadherin. Med. Sci. Monit. 2019;25:9058\u20139066. doi: 10.12659/MSM.914486.", "ArticleIdList": ["10.12659/MSM.914486", "PMC6900918", "31779025"]}, {"Citation": "Yao M.J., Fan X.D., Yuan B., Takagi N., Liu S., Han X., Ren J.G., Liu J.X. Berberine inhibits NLRP3 inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complement. Altern. Med. 2019;19:216. doi: 10.1186/s12906-019-2615-4.", "ArticleIdList": ["10.1186/s12906-019-2615-4", "PMC6694465", "31412862"]}, {"Citation": "Grivennikov S.I., Karin M. Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage. Ann. Rheum. Dis. 2011;70:I104\u2013I108. doi: 10.1136/ard.2010.140145.", "ArticleIdList": ["10.1136/ard.2010.140145", "21339211"]}, {"Citation": "Sefidabi R., Mortazavi P., Hosseini S. Antiproliferative effect of berberine on canine mammary gland cancer cell culture. Biomed. Rep. 2017;6:95\u201398. doi: 10.3892/br.2016.809.", "ArticleIdList": ["10.3892/br.2016.809", "PMC5244758", "28123715"]}, {"Citation": "Khalki L.E., Maire V., Dubois T., Zyad A. Berberine impairs the survival of triple negative breast cancer cells: Cellular and molecular analyses. Molecules. 2020;25:506. doi: 10.3390/molecules25030506.", "ArticleIdList": ["10.3390/molecules25030506", "PMC7036777", "31991634"]}, {"Citation": "Lin Y.S., Chiu Y.C., Tsai Y.H., Tsai Y.F., Wang J.Y., Tseng L.M., Chiu J.H. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines. J. Cell. Biochem. 2019;120:13531\u201313544. doi: 10.1002/jcb.28628.", "ArticleIdList": ["10.1002/jcb.28628", "30957305"]}, {"Citation": "Ahmadiankia N., Moghaddam H.K., Mishan M.A., Bahrami A.R., Meshkin H.N., Bidkhori H.R., Moghaddam M., Mirfeyzi S.J.A. Berberine suppresses migration of MCF-7 breast cancer cells through down-regulation of chemokine receptors. Iran. J. Basic Med. Sci. 2016;19:125\u2013131.", "ArticleIdList": ["PMC4818359", "27081456"]}, {"Citation": "Zhu C.Y., Li J.P., Hua Y.M., Wang J.L., Wang K., Sun J.Q. Berberine inhibits the expression of SCT through miR-214-3p stimulation in breast cancer cells. Evid. Based Complement. Altern. Med. 2020;2020:2817147. doi: 10.1155/2020/2817147.", "ArticleIdList": ["10.1155/2020/2817147", "PMC7719527", "33312221"]}, {"Citation": "Jeong Y., You D., Kang H.G., Yu J., Kim S.W., Nam S.J., Lee J.E., Kim S. Berberine suppresses fibronectin expression through inhibition of c-Jun phosphorylation in breast cancer cells. J. Breast Cancer. 2018;21:21\u201327. doi: 10.4048/jbc.2018.21.1.21.", "ArticleIdList": ["10.4048/jbc.2018.21.1.21", "PMC5880962", "29628980"]}, {"Citation": "Ouyang L., Shi Z., Zhao S., Wang F.T., Zhou T.T., Liu B., Bao J.K. Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45:487\u2013498. doi: 10.1111/j.1365-2184.2012.00845.x.", "ArticleIdList": ["10.1111/j.1365-2184.2012.00845.x", "PMC6496669", "23030059"]}, {"Citation": "Pan Y., Zhang F., Zhao Y.W., Shao D., Zheng X., Chen Y.J., He K., Li J., Chen L. Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK signaling in breast cancer. J. Cancer. 2017;8:1679\u20131689. doi: 10.7150/jca.19106.", "ArticleIdList": ["10.7150/jca.19106", "PMC5535724", "28775788"]}, {"Citation": "Sakaguchi M., Kitaguchi D., Morinami S., Kurashiki Y., Hashida H., Miyata S., Yamaguchi M., Sakai M., Murata N., Tanaka S. Berberine-induced nucleolar stress response in a human breast cancer cell line. Biochem. Biophys. Res. Commun. 2020;528:227\u2013233. doi: 10.1016/j.bbrc.2020.05.020.", "ArticleIdList": ["10.1016/j.bbrc.2020.05.020", "32475643"]}, {"Citation": "Tak J., Sabarwal A., Shyanti R.K., Singh R.P. Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells via down-regulation of Akt. Mol. Cell. Biochem. 2019;458:49\u201359. doi: 10.1007/s11010-019-03529-4.", "ArticleIdList": ["10.1007/s11010-019-03529-4", "30911957"]}, {"Citation": "Gao X.J., Wang J., Li M.Q., Wang J., Lv J., Zhang L., Sun C.F., Ji J.M., Yang W.B., Zhao Z.N., et al. Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs. J. Cell. Mol. Med. 2019;23:6797\u20136804. doi: 10.1111/jcmm.14560.", "ArticleIdList": ["10.1111/jcmm.14560", "PMC6787507", "31338966"]}, {"Citation": "Ponnusamy L., Kothandan G., Manoharan R. Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway. BBA Mol. Basis Dis. 2020;1866:165897. doi: 10.1016/j.bbadis.2020.165897.", "ArticleIdList": ["10.1016/j.bbadis.2020.165897", "32682817"]}, {"Citation": "Chen Y., Zhang H.Y. Berberine and chemotherapeutic drugs synergistically inhibits cell proliferation and migration of breast cancer cells. Int. J. Clin. Exp. Med. 2018;11:13243\u201313250."}, {"Citation": "Zhao Y.W., Jing Z.L., Li Y., Mao W.F. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncol. Rep. 2016;36:567\u2013572. doi: 10.3892/or.2016.4785.", "ArticleIdList": ["10.3892/or.2016.4785", "27177238"]}, {"Citation": "Qian K., Tang C.Y., Chen L.Y., Zheng S., Zhao Y., Ma L.S., Xu L., Fan L.H., Yu J.D., Tan H.S., et al. Berberine reverses breast cancer multidrug resistance based on fluorescence pharmacokinetics in vitro and in vivo. ACS Omega. 2021;6:10645\u201310654. doi: 10.1021/acsomega.0c06288.", "ArticleIdList": ["10.1021/acsomega.0c06288", "PMC8153757", "34056218"]}, {"Citation": "Nejman D., Livyatan I., Fuks G., Gavert N., Zwang Y., Geller L.T., Rotter-Maskowitz A., Weiser R., Mallel G., Gigi E., et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u2013980. doi: 10.1126/science.aay9189.", "ArticleIdList": ["10.1126/science.aay9189", "PMC7757858", "32467386"]}, {"Citation": "Fu A., Yao B., Dong T., Chen Y., Yao J., Liu Y., Li H., Bai H., Liu X., Zhang Y., et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185:1356\u20131372.e1326. doi: 10.1016/j.cell.2022.02.027.", "ArticleIdList": ["10.1016/j.cell.2022.02.027", "35395179"]}, {"Citation": "Deng H., Muthupalani S., Erdman S., Liu H., Niu Z., Wang T.C., Fox J.G. Translocation of Helicobacter hepaticus synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis. Oncoimmunology. 2022;11:2057399. doi: 10.1080/2162402X.2022.2057399.", "ArticleIdList": ["10.1080/2162402X.2022.2057399", "PMC8966989", "35371619"]}, {"Citation": "Wolf P.G., Devendran S., Doden H.L., Ly L.K., Moore T., Takei H., Nittono H., Murai T., Kurosawa T., Chlipala G.E., et al. Berberine alters gut microbial function through modulation of bile acids. BMC Microbiol. 2021;21:24. doi: 10.1186/s12866-020-02020-1.", "ArticleIdList": ["10.1186/s12866-020-02020-1", "PMC7798349", "33430766"]}, {"Citation": "Zheng H., Zhu F., Miao P., Mao Z., Redfearn D.P., Cao R.Y. Antimicrobial natural product berberine is efficacious for the treatment of atrial fibrillation. BioMed Res. Int. 2017;2017:3146791. doi: 10.1155/2017/3146791.", "ArticleIdList": ["10.1155/2017/3146791", "PMC5748134", "29392132"]}, {"Citation": "Huang X.X., Yi Y.L., Yong J.Y., Sun J.Y., Song Z., Li D.M., Li Y. Inhibitory effect of berberine hydrochloride against Candida albicans and the role of the HOG-MAPK pathway. J. Antibiot. 2021;74:807\u2013816. doi: 10.1038/s41429-021-00463-w.", "ArticleIdList": ["10.1038/s41429-021-00463-w", "34408288"]}, {"Citation": "Kocic B.D., Dimitrijevic M.V., Miladinovic L.C., Markovic M.S., Rankovic G.Z., Miladinovic D.L. In vitro anti-Helicobacter pylori activity of berberine and barberry extracts: A preliminary report. Nat. Prod. Commun. 2019;14:1934578X19857905. doi: 10.1177/1934578X19857905.", "ArticleIdList": ["10.1177/1934578X19857905"]}, {"Citation": "Li Y., Wen H.L., Ge X.Z. Hormesis effect of berberine against klebsiella pneumoniae is mediated by up-regulation of the efflux pump kmrA. J. Nat. Prod. 2021;84:2885\u20132892. doi: 10.1021/acs.jnatprod.1c00642.", "ArticleIdList": ["10.1021/acs.jnatprod.1c00642", "34665637"]}, {"Citation": "Tan J., Wang J., Yang C., Zhu C., Guo G., Tang J., Shen H. Antimicrobial characteristics of berberine against prosthetic joint infection-related Staphylococcus aureus of different multi-locus sequence types. BMC Complement. Altern. Med. 2019;19:218. doi: 10.1186/s12906-019-2558-9.", "ArticleIdList": ["10.1186/s12906-019-2558-9", "PMC6697971", "31419978"]}, {"Citation": "Cao S.Y., Li Y., Meng X., Zhao C.N., Li S., Gan R.Y., Li H.B. Dietary natural products and lung cancer: Effects and mechanisms of action. J. Funct. Foods. 2019;52:316\u2013331. doi: 10.1016/j.jff.2018.11.004.", "ArticleIdList": ["10.1016/j.jff.2018.11.004"]}, {"Citation": "Duma N., Santana-Davila R., Molina J.R. Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment. Mayo Clin. Proc. 2019;94:1623\u20131640. doi: 10.1016/j.mayocp.2019.01.013.", "ArticleIdList": ["10.1016/j.mayocp.2019.01.013", "31378236"]}, {"Citation": "Chen J., Huang X.F., Tao C., Wang L., Chen Z.D., Li X.P., Zeng Q., Ma M., Zhang R., Wu Z.Z. Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo. Cancer Chemother. Pharmacol. 2020;86:151\u2013161. doi: 10.1007/s00280-020-04050-y.", "ArticleIdList": ["10.1007/s00280-020-04050-y", "32607786"]}, {"Citation": "Li J., Liu F., Jiang S.L., Liu J., Chen X.H., Zhang S.N.A., Zhao H.B. Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways. Oncol. Lett. 2018;15:7409\u20137414. doi: 10.3892/ol.2018.8249.", "ArticleIdList": ["10.3892/ol.2018.8249", "PMC5920480", "29725453"]}, {"Citation": "James M.A., Fu H., Liu Y., Chen D.R., You M. Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis. Mol. Carcinog. 2011;50:1\u20137. doi: 10.1002/mc.20690.", "ArticleIdList": ["10.1002/mc.20690", "PMC6004604", "21061266"]}, {"Citation": "Ni L.L., Li Z.J., Ren H.L., Kong L.Z., Chen X., Xiong M.R., Zhang X.Q., Ning B.B., Li J.A. Berberine inhibits non-small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis. Clin. Exp. Pharmacol. Physiol. 2022;49:134\u2013144. doi: 10.1111/1440-1681.13582.", "ArticleIdList": ["10.1111/1440-1681.13582", "34448246"]}, {"Citation": "Chen Q.Q., Shi J.M., Ding Z., Xia Q., Zheng T.S., Ren Y.B., Li M., Fan L.H. Berberine induces apoptosis in non-small-cell lung cancer cells by upregulating miR-19a targeting tissue factor. Cancer Manag. Res. 2019;11:9005\u20139015. doi: 10.2147/CMAR.S207677.", "ArticleIdList": ["10.2147/CMAR.S207677", "PMC6814314", "31695492"]}, {"Citation": "Chen Q.Q., Hou Y.Q., Li D., Ding Z., Xu X., Hao B.J., Xia Q., Li M., Fan L.H. Berberine induces non-small cell lung cancer apoptosis via the activation of the ROS/ASK1/JNK pathway. Ann. Transl. Med. p. 2022. in press .", "ArticleIdList": ["10.21037/atm-22-1298", "PMC9096398", "35571453"]}, {"Citation": "Chen P., Dai C.H., Shi Z.H., Wang Y., Wu J.N., Chen K., Su J.Y., Li J. Synergistic inhibitory effect of berberine and icotinib on non-small cell lung cancer cells via inducing autophagic cell death and apoptosis. Apoptosis. 2021;26:639\u2013656. doi: 10.1007/s10495-021-01694-w.", "ArticleIdList": ["10.1007/s10495-021-01694-w", "34743246"]}, {"Citation": "Zheng F., Li J., Ma C.J., Tang X.J., Tang Q., Wu J.J., Chai X.S., Xie J.H., Yang X.B., Hann S.S. Novel regulation of miR-34a-5p and HOTAIR by the combination of berberine and gefitinib leading to inhibition of EMT in human lung cancer. J. Cell. Mol. Med. 2020;24:5578\u20135592. doi: 10.1111/jcmm.15214.", "ArticleIdList": ["10.1111/jcmm.15214", "PMC7214156", "32248643"]}, {"Citation": "Mao Q.Q., Xu X.Y., Shang A., Gan R.Y., Wu D.T., Atanasov A.G., Li H.B. Phytochemicals for the prevention and treatment of gastric cancer: Effects and mechanisms. Int. J. Mol. Sci. 2020;21:570. doi: 10.3390/ijms21020570.", "ArticleIdList": ["10.3390/ijms21020570", "PMC7014214", "31963129"]}, {"Citation": "Smyth E.C., Nilsson M., Grabsch H.I., van Grieken N.C.T., Lordick F. Gastric cancer. Lancet. 2020;396:635\u2013648. doi: 10.1016/S0140-6736(20)31288-5.", "ArticleIdList": ["10.1016/S0140-6736(20)31288-5", "32861308"]}, {"Citation": "Yang Y.H., Zhang N., Li K.D., Chen J., Qiu L., Zhang J.F. Integration of microRNA-mRNA profiles and pathway analysis of plant isoquinoline alkaloid berberine in SGC-7901 gastric cancers cells. Drug Des. Dev. Ther. 2018;12:393\u2013408. doi: 10.2147/DDDT.S155993.", "ArticleIdList": ["10.2147/DDDT.S155993", "PMC5836656", "29535501"]}, {"Citation": "Li H.L., Wu H., Zhang B.B., Shi H.L., Wu X.J. MAPK pathways are involved in the inhibitory effect of berberine hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8 secretion in vitro and in vivo. Mol. Med. Rep. 2016;14:1430\u20131438. doi: 10.3892/mmr.2016.5361.", "ArticleIdList": ["10.3892/mmr.2016.5361", "27278862"]}, {"Citation": "Wang J.X., Yang S., Cai X.Q., Dong J.Q., Chen Z.Q., Wang R., Zhang S., Cao H.C., Lu D., Jin T., et al. Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer. Oncotarget. 2016;7:76076\u201376086. doi: 10.18632/oncotarget.12589.", "ArticleIdList": ["10.18632/oncotarget.12589", "PMC5342797", "27738318"]}, {"Citation": "Zhang Q., Wang X.B., Cao S.J., Sun Y.J., He X.Y., Jiang B.K., Yu Y.Q., Duan J.S., Qiu F., Kang N. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. Biomed. Pharmacother. 2020;128:110245. doi: 10.1016/j.biopha.2020.110245.", "ArticleIdList": ["10.1016/j.biopha.2020.110245", "32454290"]}, {"Citation": "Wang M., Sun L.T., Wang L., Sun Y.N. Effects of berberine on circular RNA expression profiles in human gastric cancer cells. Evid. Based Complement. Altern. Med. 2021;2021:6688629. doi: 10.1155/2021/6688629.", "ArticleIdList": ["10.1155/2021/6688629", "PMC8112944", "34055022"]}, {"Citation": "Kou Y.Y., Tong B.D., Wu W.Q., Liao X.Q., Zhao M. Berberine improves chemo-sensitivity to cisplatin by enhancing cell apoptosis and repressing PI3K/AKT/mTOR signaling pathway in gastric cancer. Front. Pharmacol. 2020;11:616251. doi: 10.3389/fphar.2020.616251.", "ArticleIdList": ["10.3389/fphar.2020.616251", "PMC7756080", "33362566"]}, {"Citation": "You H.Y., Xie X.M., Zhang W.J., Zhu H.L., Jiang F.Z. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203. In Vitro Cell Dev. Biol. Anim. 2016;52:857\u2013863. doi: 10.1007/s11626-016-0044-y.", "ArticleIdList": ["10.1007/s11626-016-0044-y", "27142767"]}, {"Citation": "Llovet J.M., Kelley R.K., Villanueva A., Singal A.G., Pikarsky E., Roayaie S., Lencioni R., Koike K., Zucman-Rossi J., Finn R.S. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 2021;7:6. doi: 10.1038/s41572-020-00240-3.", "ArticleIdList": ["10.1038/s41572-020-00240-3", "33479224"]}, {"Citation": "Zhou Y., Li Y., Zhou T., Zheng J., Li S., Li H.B. Dietary natural products for prevention and treatment of liver cancer. Nutrients. 2016;8:156. doi: 10.3390/nu8030156.", "ArticleIdList": ["10.3390/nu8030156", "PMC4808884", "26978396"]}, {"Citation": "Zhang P.C., Wang Q.C., Lin Z.B., Yang P.J., Dou K.F., Zhang R.H. Berberine inhibits growth of liver cancer cells by suppressing glutamine uptake. OncoTargets Ther. 2019;12:1751\u20131763. doi: 10.2147/OTT.S235667.", "ArticleIdList": ["10.2147/OTT.S235667", "PMC6978679", "32021249"]}, {"Citation": "Mustafa K., Mohamed H., Shah A.M., Yu S.X., Akhlaq M., Xiao H.F., Li S.Q., Naz T., Nosheen S., Bai X.Y., et al. In vitro anticancer potential of Berberis lycium Royle extracts against human hepatocarcinoma (HepG2) cells. BioMed Res. Int. 2020;2020:8256809. doi: 10.1155/2020/8256809.", "ArticleIdList": ["10.1155/2020/8256809", "PMC7582056", "33110920"]}, {"Citation": "Huang Y.Z., Wang K.Y., Gu C.X., Yu G.X., Zhao D., Mai W.J., Zhong Y., Liu S.M., Nie Y.Q., Yang H. Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib. Oncol. Rep. 2018;40:1525\u20131532. doi: 10.3892/or.2018.6552.", "ArticleIdList": ["10.3892/or.2018.6552", "30015938"]}, {"Citation": "Llovet J.M., Zucman-Rossi J., Pikarsky E., Sangro B., Schwartz M., Sherman M., Gores G. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 2016;2:16018. doi: 10.1038/nrdp.2016.18.", "ArticleIdList": ["10.1038/nrdp.2016.18", "27158749"]}, {"Citation": "Shu X.B., Li M., Cao Y., Li C.L., Zhou W.J., Ji G., Zhang L. Berberine alleviates non-alcoholic steatohepatitis through modulating gut microbiota mediated intestinal FXR activation. Front. Pharmacol. 2021;12:750826. doi: 10.3389/fphar.2021.750826.", "ArticleIdList": ["10.3389/fphar.2021.750826", "PMC8484326", "34603061"]}, {"Citation": "Li S., Wang N., Tan H.Y., Chueng F., Zhang Z.J., Yuen M.F., Feng Y.B. Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. Clin. Transl. Med. 2020;10:e112. doi: 10.1002/ctm2.112.", "ArticleIdList": ["10.1002/ctm2.112", "PMC7438809", "32790968"]}, {"Citation": "Dekker E., Tanis P.J., Vleugels J.L.A., Kasi P.M., Wallace M.B. Colorectal cancer. Lancet. 2019;394:1467\u20131480. doi: 10.1016/S0140-6736(19)32319-0.", "ArticleIdList": ["10.1016/S0140-6736(19)32319-0", "31631858"]}, {"Citation": "Tao J., Li Y., Li S., Li H.B. Plant foods for the prevention and management of colon cancer. J. Funct. Foods. 2018;42:95\u2013110. doi: 10.1016/j.jff.2017.12.064.", "ArticleIdList": ["10.1016/j.jff.2017.12.064"]}, {"Citation": "Zhao Z.Y., Zeng J.H., Guo Q., Pu K.M., Yang Y., Chen N.Z., Zhang G., Zhao M.Y., Zheng Q., Tang J.Y., et al. Berberine suppresses stemness and tumorigenicity of colorectal cancer stem-like cells byinhibiting m(6)A methylation. Front. Oncol. 2021;11:775418. doi: 10.3389/fonc.2021.775418.", "ArticleIdList": ["10.3389/fonc.2021.775418", "PMC8634032", "34869024"]}, {"Citation": "Nie Q.H., Peng W.W., Wang Y.L., Zhong L.T., Zhang X.B., Zeng L. \u03b2-catenin correlates with the progression of colon cancers and berberine inhibits the proliferation of colon cancer cells by regulating the \u03b2-catenin signaling pathway. Gene. 2022;818:146207. doi: 10.1016/j.gene.2022.146207.", "ArticleIdList": ["10.1016/j.gene.2022.146207", "35063579"]}, {"Citation": "Ruan H., Zhan Y.Y., Hou J., Xu B., Chen B., Tian Y., Wu D., Zhao Y., Zhang Y., Chen X., et al. Berberine binds RXR alpha to suppress beta-catenin signaling in colon cancer cells. Oncogene. 2017;36:6906\u20136918. doi: 10.1038/onc.2017.296.", "ArticleIdList": ["10.1038/onc.2017.296", "PMC5735301", "28846104"]}, {"Citation": "Li P.F., Hao Z.F., Liu H.H., Zhu B.J., Dang L.Y., Ma C., Xu Y.T., Zhang Y.Y., Fan D.D., Sun S.S. Quantitative proteomics analysis of berberine-treated colon cancer cells reveals potential therapy targets. Biology. 2021;10:250. doi: 10.3390/biology10030250.", "ArticleIdList": ["10.3390/biology10030250", "PMC8005188", "33806918"]}, {"Citation": "Samad M.A., Saiman M.Z., Majid N.A., Karsani S.A., Yaacob J.S. Berberine inhibits telomerase activity and induces cell cycle arrest and telomere erosion in colorectal cancer cell line, HCT 116. Molecules. 2021;26:376. doi: 10.3390/molecules26020376.", "ArticleIdList": ["10.3390/molecules26020376", "PMC7828342", "33450878"]}, {"Citation": "Liu Y.X., Hua W.W., Li Y., Xian X.R., Zhao Z., Liu C., Zou J.J., Li J., Fang X.J., Zhu Y.B. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis. Biochem. Pharmacol. 2020;174:113776. doi: 10.1016/j.bcp.2019.113776.", "ArticleIdList": ["10.1016/j.bcp.2019.113776", "31874145"]}, {"Citation": "Zhang Y.R., Liu X.J., Yu M., Xu M.M., Xiao Y.P., Ma W.Y., Huang L., Li X.G., Ye X.L. Berberine inhibits proliferation and induces G0/G1 phase arrest in colorectal cancer cells by downregulating IGF2BP3. Life Sci. 2020;260:118413. doi: 10.1016/j.lfs.2020.118413.", "ArticleIdList": ["10.1016/j.lfs.2020.118413", "32926933"]}, {"Citation": "Liu Y.X., Fang X.J., Li Y., Bing L., Li Y., Fang J., Xian X.R., Zhang W., Li J., Zhao Z., et al. Berberine suppresses the migration and invasion of colon cancer cells by inhibition of lipogenesis through modulation of promyelocytic leukemia zinc finger-mediated sterol-regulatory element binding proteins cleavage-activating protein ubiquitination. J. Pharm. Pharmacol. p. 2022. in press .", "ArticleIdList": ["10.1093/jpp/rgac026", "35641094"]}, {"Citation": "Gong C.X., Hu X., Xu Y.L., Yang J.H., Zong L., Wang C., Zhu J., Li Z.Y., Lu D.Z. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78. Anti-Cancer Drugs. 2020;31:141\u2013149. doi: 10.1097/CAD.0000000000000835.", "ArticleIdList": ["10.1097/CAD.0000000000000835", "31743135"]}, {"Citation": "L\u00fc Y., Han B., Yu H., Cui Z., Li Z., Wang J. Berberine regulates the microRNA-21-ITG\u03924-PDCD4 axis and inhibits colon cancer viability. Oncol. Lett. 2018;15:5971\u20135976. doi: 10.3892/ol.2018.7997.", "ArticleIdList": ["10.3892/ol.2018.7997", "PMC5858122", "29564000"]}, {"Citation": "Dai W., Mu L.Y., Cui Y.L., Li Y.Y., Chen P., Xie H.J., Wang X. Berberine promotes apoptosis of colorectal cancer via regulation of the long non-coding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2)/AU-binding factor 1 (AUF1)/B-cell CLL/Lymphoma 2 (Bcl-2) axis. Med. Sci. Monit. 2019;25:730\u2013738. doi: 10.12659/MSM.912082.", "ArticleIdList": ["10.12659/MSM.912082", "PMC6357823", "30681073"]}, {"Citation": "Fu T., Coulter S., Yoshihara E., Oh T.G., Fang S., Cayabyab F., Zhu Q.Y., Zhang T., Leblanc M., Liu S.H., et al. FXR regulates intestinal cancer stem cell proliferation. Cell. 2019;176:1098\u20131112.e1018. doi: 10.1016/j.cell.2019.01.036.", "ArticleIdList": ["10.1016/j.cell.2019.01.036", "PMC6701863", "30794774"]}, {"Citation": "Tian Y., Cai J.W., Gui W., Nichols R.G., Koo I., Zhang J.T., Anitha M., Patterson A.D. Berberine directly affects the gut microbiota to promote intestinal farnesoid X receptor activation. Drug Metab. Dispos. 2019;47:86\u201393. doi: 10.1124/dmd.118.083691.", "ArticleIdList": ["10.1124/dmd.118.083691", "PMC6323626", "30409838"]}, {"Citation": "Deng J., Zhao L., Yuan X., Li Y., Shi J., Zhang H., Zhao Y., Han L., Wang H., Yan Y., et al. Pre-administration of berberine exerts chemopreventive effects in AOM/DSS-induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota. Nutrients. 2022;14:726. doi: 10.3390/nu14040726.", "ArticleIdList": ["10.3390/nu14040726", "PMC8879943", "35215376"]}, {"Citation": "Okuno K., Garg R., Yuan Y.C., Tokunaga M., Kinugasa Y., Goel A. Berberine and oligomeric proanthocyanidins exhibit synergistic efficacy through regulation of PI3K-Akt signaling pathway in colorectal cancer. Front. Oncol. 2022;12:855860. doi: 10.3389/fonc.2022.855860.", "ArticleIdList": ["10.3389/fonc.2022.855860", "PMC9114748", "35600365"]}, {"Citation": "Matulonis U.A., Sood A.K., Fallowfield L., Howitt B.E., Sehouli J., Karlan B.Y. Ovarian cancer. Nat. Rev. Dis. Prim. 2016;2:16061. doi: 10.1038/nrdp.2016.61.", "ArticleIdList": ["10.1038/nrdp.2016.61", "PMC7290868", "27558151"]}, {"Citation": "Li J., Zou Y.L., Pei M.L., Zhang Y., Jiang Y. Berberine inhibits the Warburg effect through TET3/miR-145/HK2 pathways in ovarian cancer cells. J. Cancer. 2021;12:207\u2013216. doi: 10.7150/jca.48896.", "ArticleIdList": ["10.7150/jca.48896", "PMC7738813", "33391417"]}, {"Citation": "Zhao Y.W., Yang X.H., Zhao J.T., Gao M.H., Zhang M., Shi T.F., Zhang F., Zheng X., Pan Y., Shao D., et al. Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1. Eur. J. Pharmacol. 2021;895:173887. doi: 10.1016/j.ejphar.2021.173887.", "ArticleIdList": ["10.1016/j.ejphar.2021.173887", "33482182"]}, {"Citation": "Parashar D., Nair B., Geethadevi A., George J., Nair A., Tsaih S.W., Kadamberi I.P., Nair G.K.G., Lu Y.L., Ramchandran R., et al. Peritoneal spread of ovarian cancer harbors therapeutic vulnerabilities regulated by FOXM1 and EGFR/ERBB2 signaling. Cancer Res. 2020;80:5554\u20135568. doi: 10.1158/0008-5472.CAN-19-3717.", "ArticleIdList": ["10.1158/0008-5472.CAN-19-3717", "PMC7744365", "33087324"]}, {"Citation": "Chuang T.C., Wu K.H., Lin Y.Y., Kuo H.P., Kao M.C., Wang V., Hsu S.C., Lee S.L. Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells. Environ. Toxicol. 2021;36:737\u2013747. doi: 10.1002/tox.23076.", "ArticleIdList": ["10.1002/tox.23076", "33325633"]}, {"Citation": "Liu L., Fan J.Y., Ai G.H., Liu J., Luo N., Li C.X., Cheng Z.P. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol. Res. 2019;52:37. doi: 10.1186/s40659-019-0243-6.", "ArticleIdList": ["10.1186/s40659-019-0243-6", "PMC6637630", "31319879"]}, {"Citation": "Zhao Y.W., Cui L.Z., Pan Y., Shao D., Zheng X., Zhang F., Zhang H.S., He K., Chen L. Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer. Cell Prolif. 2017;50:e12393. doi: 10.1111/cpr.12393.", "ArticleIdList": ["10.1111/cpr.12393", "PMC6529084", "28990249"]}, {"Citation": "Hou D., Xu G.W., Zhang C.B., Li B.X., Qin J.C., Hao X.H., Liu Q., Zhang X.Y., Liu J.S., Wei J.J., et al. Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition. Cell Death Dis. 2017;8:e3070. doi: 10.1038/cddis.2017.471.", "ArticleIdList": ["10.1038/cddis.2017.471", "PMC5680592", "28981112"]}, {"Citation": "Cohen P.A., Jhingran A., Oaknin A., Denny L. Cervical cancer. Lancet. 2019;393:169\u2013182. doi: 10.1016/S0140-6736(18)32470-X.", "ArticleIdList": ["10.1016/S0140-6736(18)32470-X", "30638582"]}, {"Citation": "Liu L.P., Sun L., Zheng J., Cui L. Berberine modulates Keratin 17 to inhibit cervical cancer cell viability and metastasis. J. Recept. Signal Transduct. 2021;41:521\u2013531. doi: 10.1080/10799893.2020.1830110.", "ArticleIdList": ["10.1080/10799893.2020.1830110", "33045871"]}, {"Citation": "Chu S.C., Yu C.C., Hsu L.S., Chen K.S., Su M.Y., Chen P.N. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells. Mol. Pharmacol. 2014;86:609\u2013623. doi: 10.1124/mol.114.094037.", "ArticleIdList": ["10.1124/mol.114.094037", "25217495"]}, {"Citation": "Zhang Q., Sun Y., Huang Y., Sun J., Zhao C., Song Y., Wu J. Combination of berberine and matrine affects apoptosis and cellcycle in human cervical cancer cells. Acta Pol. Pharm. 2019;76:1089\u20131097. doi: 10.32383/appdr/112478.", "ArticleIdList": ["10.32383/appdr/112478"]}, {"Citation": "Zeng X., Wan L., Wang Y., Xue J., Yang H., Zhu Y. Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF-1 pathway under nutrient-deprived conditions. Int. J. Radiat. Biol. 2020;96:1060\u20131067. doi: 10.1080/09553002.2020.1770358.", "ArticleIdList": ["10.1080/09553002.2020.1770358", "32412317"]}, {"Citation": "Rebello R.J., Oing C., Knudsen K.E., Loeb S., Johnson D.C., Reiter R.E., Gillessen S., Van der Kwast T., Bristow R.G. Prostate cancer. Nat. Rev. Dis. Prim. 2021;7:9. doi: 10.1038/s41572-020-00243-0.", "ArticleIdList": ["10.1038/s41572-020-00243-0", "33542230"]}, {"Citation": "Li X.N., Zhang A.H., Sun H., Liu Z.D., Zhang T.L., Qiu S., Liu L., Wang X.J. Metabolic characterization and pathway analysis of berberine protects against prostate cancer. Oncotarget. 2017;8:65022\u201365041. doi: 10.18632/oncotarget.17531.", "ArticleIdList": ["10.18632/oncotarget.17531", "PMC5630309", "29029409"]}, {"Citation": "Zenata O., Dvorak Z., Vrzal R. Pharmacologically relevant concentrations of berberine transiently stimulate dihydrotestosterone-inducible androgen receptor-mediated luciferase activity in human prostate cancer cells. Transl. Cancer Res. 2018;7:383\u2013390. doi: 10.21037/tcr.2018.03.31.", "ArticleIdList": ["10.21037/tcr.2018.03.31"]}, {"Citation": "Tian Y.T., Zhao L.J., Wang Y., Zhang H.T., Xu D., Zhao X.J., Li Y., Li J. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells. Asian J. Androl. 2016;18:607\u2013612. doi: 10.4103/1008-682X.169997.", "ArticleIdList": ["10.4103/1008-682X.169997", "PMC4955188", "26698234"]}, {"Citation": "Huang Z.H., Zheng H.F., Wang W.L., Wang Y., Zhong L.F., Wu J.L., Li Q.X. Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro. Mol. Med. Rep. 2015;11:2125\u20132128. doi: 10.3892/mmr.2014.2929.", "ArticleIdList": ["10.3892/mmr.2014.2929", "25394789"]}, {"Citation": "Liu C.H., Tang W.C., Sia P., Huang C.C., Yang P.M., Wu M.H., Lai I.L., Lee K.H. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. Int. J. Med. Sci. 2015;12:63\u201371. doi: 10.7150/ijms.9982.", "ArticleIdList": ["10.7150/ijms.9982", "PMC4278877", "25552920"]}, {"Citation": "Zhang Q., Zhang C., Yang X., Yang B., Wang J., Kang Y., Wang Z., Li D., Huang G., Ma Z., et al. Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer. Diagn. Pathol. 2014;9:98. doi: 10.1186/1746-1596-9-98.", "ArticleIdList": ["10.1186/1746-1596-9-98", "PMC4051149", "24886405"]}, {"Citation": "Gao X.H., Liu J.K., Fan D.M., Li X.F., Fang Z.Q., Yan K.Q., Fan Y.D. Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Oncol. Rep. 2022;47:33. doi: 10.3892/or.2021.8244.", "ArticleIdList": ["10.3892/or.2021.8244", "34935059"]}, {"Citation": "Zhuo Y.M., Chen Q.B., Chen B., Zhan X.Y., Qin X.P., Huang J., Lv X.X. Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest. Int. J. Clin. Pharmacol. Ther. 2017;55:32\u201340. doi: 10.5414/CP202534.", "ArticleIdList": ["10.5414/CP202534", "27719740"]}, {"Citation": "Wang Y., Zhang S.L. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Biomed. Pharmacother. 2018;103:1287\u20131293. doi: 10.1016/j.biopha.2018.04.161.", "ArticleIdList": ["10.1016/j.biopha.2018.04.161", "29864910"]}, {"Citation": "Liu J., Luo X., Guo R., Jing W., Lu H. Cell metabolomics reveals berberine-inhibited pancreatic cancer cell viability and metastasis by regulating citrate metabolism. J. Proteome Res. 2020;19:3825\u20133836. doi: 10.1021/acs.jproteome.0c00394.", "ArticleIdList": ["10.1021/acs.jproteome.0c00394", "32692565"]}, {"Citation": "Och A., Zalewski D., Komsta \u0141., Ko\u0142odziej P., Kocki J., Bogucka-Kocka A. Cytotoxic and proapoptotic activity of sanguinarine, berberine, and extracts of Chelidonium majus L. and Berberis thunbergii DC. toward hematopoietic cancer cell lines. Toxins. 2019;11:485. doi: 10.3390/toxins11090485.", "ArticleIdList": ["10.3390/toxins11090485", "PMC6784183", "31443589"]}, {"Citation": "Jiang S.X., Qi B., Yao W.J., Gu C.W., Wei X.F., Zhao Y., Liu Y.Z., Zhao B.S. Berberine displays antitumor activity in esophageal cancer cells in vitro. World J. Gastroenterol. 2017;23:2511\u20132518. doi: 10.3748/wjg.v23.i14.2511.", "ArticleIdList": ["10.3748/wjg.v23.i14.2511", "PMC5394514", "28465635"]}, {"Citation": "Ren K., Zhang W., Wu G., Ren J., Lu H., Li Z., Han X. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells. Biomed. Pharmacother. 2016;84:1748\u20131759. doi: 10.1016/j.biopha.2016.10.111.", "ArticleIdList": ["10.1016/j.biopha.2016.10.111", "27876206"]}, {"Citation": "Naveen C.R., Gaikwad S., Agrawal-Rajput R. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells. Phytomedicine. 2016;23:736\u2013744. doi: 10.1016/j.phymed.2016.03.013.", "ArticleIdList": ["10.1016/j.phymed.2016.03.013", "27235712"]}, {"Citation": "Gao X., Zhang C., Wang Y., Zhang P., Zhang J., Hong T. Berberine and cisplatin exhibit synergistic anticancer effects on osteosarcoma MG-63 cells by inhibiting the MAPK pathway. Molecules. 2021;26:1666. doi: 10.3390/molecules26061666.", "ArticleIdList": ["10.3390/molecules26061666", "PMC8002572", "33802664"]}, {"Citation": "Tong M.F., Liu H.M., Hao J.Y., Fan D.M. Comparative pharmacoproteomics reveals potential targets for berberine, a promising therapy for colorectal cancer. Biochem. Biophys. Res. Commun. 2020;525:244\u2013250. doi: 10.1016/j.bbrc.2020.02.052.", "ArticleIdList": ["10.1016/j.bbrc.2020.02.052", "32087971"]}, {"Citation": "Liu H., Huang C., Wu L.Y., Wen B. Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer. OncoTargets Ther. 2016;9:4121\u20134126. doi: 10.2147/OTT.S104729.", "ArticleIdList": ["10.2147/OTT.S104729", "PMC4940014", "27462166"]}, {"Citation": "Lin J.P., Yang J.S., Chang N.W., Chiu T.H., Su C.C., Lu K.W., Ho Y.T., Yeh C.C., Mei D., Lin H.J., et al. GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res. 2007;27:3379\u20133386.", "ArticleIdList": ["17970084"]}, {"Citation": "Bhanumathi R., Vimala K., Shanthi K., Thangaraj R., Kannan S. Bioformulation of silver nanoparticles as berberine carrier cum anticancer agent against breast cancer. New J. Chem. 2017;41:14466\u201314477. doi: 10.1039/C7NJ02531A.", "ArticleIdList": ["10.1039/C7NJ02531A"]}, {"Citation": "Hu S.W., Zhao R.C., Liu Y.H., Chen J.Z., Zheng Z.J., Wang S.S. Preventive and therapeutic roles of berberine in gastrointestinal cancers. BioMed Res. Int. 2019;2019:6831520. doi: 10.1155/2019/6831520.", "ArticleIdList": ["10.1155/2019/6831520", "PMC6949668", "31950049"]}, {"Citation": "Paudel K.R., Mehta M., Yin G.H.S., Yen L.L., Malyla V., Patel V.K., Panneerselvam J., Madheswaran T., MacLoughlin R., Jha N.K., et al. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Environ. Sci. Pollut. Res. Int. 2022;29:46830\u201346847. doi: 10.1007/s11356-022-19158-2.", "ArticleIdList": ["10.1007/s11356-022-19158-2", "PMC9232428", "35171422"]}, {"Citation": "Yue J., Wang Z., Shao D., Chang Z., Hu R., Li L., Luo S.Z., Dong W.F. Cancer cell membrane-modified biodegradable mesoporous silica nanocarriers for berberine therapy of liver cancer. RSC Adv. 2018;8:40288\u201340297. doi: 10.1039/C8RA07574C.", "ArticleIdList": ["10.1039/C8RA07574C", "PMC9091357", "35558223"]}, {"Citation": "Shen R., Kim J.J., Yao M., Elbayoumi T.A. Development and evaluation of vitamin E d-\u03b1-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical. Int. J. Nanomed. 2016;11:1687\u20131700. doi: 10.2147/ijn.S103332.", "ArticleIdList": ["10.2147/ijn.S103332", "PMC4853014", "27217747"]}, {"Citation": "Othman M.S., Obeidat S.T., Al-Bagawi A.H., Fareid M.A., Fehaid A., Moneim A.E.A. Green-synthetized selenium nanoparticles using berberine as a promising anticancer agent. J. Integr. Med. 2022;20:65\u201372. doi: 10.1016/j.joim.2021.11.002.", "ArticleIdList": ["10.1016/j.joim.2021.11.002", "34802980"]}, {"Citation": "Thomas A., Kamble S., Deshkar S., Kothapalli L., Chitlange S. Bioavailability of berberine: Challenges and solutions. Istanb. J. Pharm. 2021;51:141\u2013153. doi: 10.26650/IstanbulJPharm.2020.0056.", "ArticleIdList": ["10.26650/IstanbulJPharm.2020.0056"]}, {"Citation": "Och A., Podgorski R., Nowak R. Biological activity of berberine-a summary update. Toxins. 2020;12:713. doi: 10.3390/toxins12110713.", "ArticleIdList": ["10.3390/toxins12110713", "PMC7697704", "33198257"]}, {"Citation": "Fang S., Guo S., Du S., Cao Z., Yang Y., Su X., Wei W. Efficacy and safety of berberine in preventing recurrence of colorectal adenomas: A systematic review and meta-analysis. J. Ethnopharmacol. 2022;282:114617. doi: 10.1016/j.jep.2021.114617.", "ArticleIdList": ["10.1016/j.jep.2021.114617", "34509605"]}, {"Citation": "Mirzaee F., Razmjouei P., Shahrahmani H., Vafisani F., Najafi M.N., Ghazanfarpour M. The effect and safety of Berberine on polycystic ovary syndrome: A systematic review. J. Obstet. Gynaecol. 2021;41:684\u2013689. doi: 10.1080/01443615.2020.1787964.", "ArticleIdList": ["10.1080/01443615.2020.1787964", "32811221"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "31"}, {"Year": "2022", "Month": "7", "Day": "11"}, {"Year": "2022", "Month": "7", "Day": "12"}, {"Year": "2022", "Month": "7", "Day": "27", "Hour": "1", "Minute": "34"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["35889396", "PMC9316001", "10.3390/molecules27144523", "molecules27144523"]}}], "PubmedBookArticle": []}